192 related articles for article (PubMed ID: 37022638)
21. Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
Ye T; Bartlett MJ; Sherman SJ; Falk T; Cowen SL
Exp Neurol; 2021 Jun; 340():113670. PubMed ID: 33662379
[TBL] [Abstract][Full Text] [Related]
22. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats.
Tronci E; Napolitano F; Muñoz A; Fidalgo C; Rossi F; Björklund A; Usiello A; Carta M
Exp Neurol; 2017 Nov; 297():73-81. PubMed ID: 28757258
[TBL] [Abstract][Full Text] [Related]
23. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
[TBL] [Abstract][Full Text] [Related]
24. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons.
Klietz M; Keber U; Carlsson T; Chiu WH; Höglinger GU; Weihe E; Schäfer MK; Depboylu C
Neuroscience; 2016 Sep; 331():120-33. PubMed ID: 27320210
[TBL] [Abstract][Full Text] [Related]
25. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
[TBL] [Abstract][Full Text] [Related]
26. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
[TBL] [Abstract][Full Text] [Related]
27. Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
Andreoli L; Abbaszadeh M; Cao X; Cenci MA
Neurobiol Dis; 2021 Sep; 157():105429. PubMed ID: 34153463
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
[TBL] [Abstract][Full Text] [Related]
29. Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.
Steece-Collier K; Collier TJ; Lipton JW; Stancati JA; Winn ME; Cole-Strauss A; Sellnow R; Conti MM; Mercado NM; Nillni EA; Sortwell CE; Manfredsson FP; Bishop C
Exp Neurol; 2020 Aug; 330():113327. PubMed ID: 32387398
[TBL] [Abstract][Full Text] [Related]
30. GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming.
Nishijima H; Mori F; Arai A; Zhu G; Wakabayashi K; Okada M; Ueno S; Ichinohe N; Suzuki C; Kon T; Tomiyama M
Neurobiol Dis; 2020 Sep; 143():104979. PubMed ID: 32590036
[TBL] [Abstract][Full Text] [Related]
31. The Vasomotor Response to Dopamine Is Altered in the Rat Model of l-dopa-Induced Dyskinesia.
Booth S; Ramadan A; Zhang D; Lu L; Kirouac G; Jackson MF; Anderson C; Ko JH
Mov Disord; 2021 Apr; 36(4):938-947. PubMed ID: 33135810
[TBL] [Abstract][Full Text] [Related]
32. Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.
Keifman E; Ruiz-DeDiego I; Pafundo DE; Paz RM; Solís O; Murer MG; Moratalla R
Br J Pharmacol; 2019 Jul; 176(13):2146-2161. PubMed ID: 30895594
[TBL] [Abstract][Full Text] [Related]
33. Behavioral and cellular dopamine D
Lanza K; Meadows SM; Chambers NE; Nuss E; Deak MM; Ferré S; Bishop C
Neuropharmacology; 2018 Aug; 138():304-314. PubMed ID: 29936243
[TBL] [Abstract][Full Text] [Related]
34. Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.
Bhide N; Lindenbach D; Barnum CJ; George JA; Surrena MA; Bishop C
J Neurochem; 2015 Jul; 134(2):222-32. PubMed ID: 25866285
[TBL] [Abstract][Full Text] [Related]
35. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
[TBL] [Abstract][Full Text] [Related]
36. The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia.
Flores AJ; Bartlett MJ; Root BK; Parent KL; Heien ML; Porreca F; Polt R; Sherman SJ; Falk T
Neuropharmacology; 2018 Oct; 141():260-271. PubMed ID: 30201210
[TBL] [Abstract][Full Text] [Related]
37. Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia.
Gangarossa G; Guzman M; Prado VF; Prado MA; Daumas S; El Mestikawy S; Valjent E
Neurobiol Dis; 2016 Mar; 87():69-79. PubMed ID: 26711621
[TBL] [Abstract][Full Text] [Related]
38. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
Mulas G; Espa E; Fenu S; Spiga S; Cossu G; Pillai E; Carboni E; Simbula G; Jadžić D; Angius F; Spolitu S; Batetta B; Lecca D; Giuffrida A; Carta AR
Exp Neurol; 2016 Dec; 286():83-92. PubMed ID: 27697481
[TBL] [Abstract][Full Text] [Related]
39. Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's rats.
Zhang S; Xie C; Wang Q; Liu Z
Sci Rep; 2014 Oct; 4():6811. PubMed ID: 25351365
[TBL] [Abstract][Full Text] [Related]
40. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
